Thaddeus Shattuck, MD
Psychiatry · Lewiston, MENPI 1285798447
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $807 of the $968 with a category attached, or 83.4%. 9 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 55.6% of the total. Reporting peaked in 2024 at $629 and has fallen 75.2% since, to $156 in 2025. Among psychiatry clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $29.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$538
- Harmony Biosciences LLC$199
- Philips North America LLC$54
- Inspire Medical Systems, Inc.$50
- Sanofi$43
- Mallinckrodt Hospital Products Inc.$28
- plus $56 from 3 others
What the payments were for
- Food & beverage$80783%
- Education$16117%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 16 | $538 |
| Harmony Biosciences LLC | 7 | $199 |
| Philips North America LLC | 2 | $54 |
| Inspire Medical Systems, Inc. | 2 | $50 |
| Sanofi | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| GSK | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$118
How this compares
$968 in reported general payments places this provider in the 90th percentile of 167 psychiatry providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 13 | $206,661 |
| IngrezzaValbenazine Tosylate | 13 | $105,254 |
| VraylarCariprazine Hcl | 13 | $21,488 |
| RexultiBrexpiprazole | 15 | $20,999 |
| Lurasidone Hcl | 62 | $14,830 |
| NeuproRotigotine | 12 | $9,779 |
| Chlorpromazine Hcl | 40 | $7,051 |
| Atomoxetine Hcl | 27 | $5,995 |
| Modafinil | 31 | $5,082 |
| Doxepin Hcl | 20 | $3,943 |
| Clomipramine Hcl | 14 | $2,935 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $2,743 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $2,001 |
| Clozapine | 21 | $1,933 |
| Pregabalin | 25 | $1,630 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lewiston
- Elliot GruenLewiston$7K
- Brigitte HristeaLewiston$779
- Colin PopeLewiston$263
- Ryan SmithEastport$92K
- Edward BilottiSouth Portland$88K
- Ira ScottBangor$27K
- Charmaine PatelBangor$17K
- Glenn CurrierPortland$8K
- David JonesArundel$5K
- Christine WhitePrinceton$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.